Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2014-04-22 09:36 |
PHARMING ANNOUNCES (“SUB 10%”) €14.7 MILLION PRIVATE EQUITY PLACEMENT WITH INST…
|
English | 76.1 KB | ||
| 2014-03-06 08:26 |
PHARMING REPORTS ON PRELIMINARY FINANCIAL RESULTS 2013
|
English | 336.5 KB | ||
| 2014-02-24 08:51 |
PHARMING AND SALIX ANNOUNCE EXTENSION OF PDUFA ACTION DATE FOR RUCONEST®
|
English | 164.3 KB | ||
| 2014-01-15 08:49 |
Pharming’s Partner, MegaPharm, Receive Marketing Authorisation For Ruconest® In…
|
English | 201.9 KB | ||
| 2013-12-16 11:26 | English | 432.1 KB | |||
| 2013-11-08 08:37 |
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY …
|
English | 244.9 KB | ||
| 2013-11-07 07:55 |
PHARMING REPORTS ON FINANCIAL RESULTS FOR THE FIRST NINE MONTHS OF 2013
|
English | 491.8 KB | ||
| 2013-10-09 08:23 |
PHARMING ANNOUNCES €12.0 MILLION PRIVATE EQUITY PLACEMENT WITH INSTITUTIONAL IN…
|
English | 182.5 KB | ||
| 2013-08-30 08:41 |
Pharming Redeems Final Tranche Of Convertible Bond For Cash
|
English | 182.4 KB | ||
| 2013-08-01 08:48 |
PHARMING REPORTS ON FINANCIAL RESULTS FIRST HALF YEAR 2013
|
English | 485.1 KB | ||
| 2013-08-01 07:07 | English | 485.1 KB | |||
| 2013-07-29 08:27 |
PHARMING REDEEMS SIXTH TRANCHE OF CONVERTIBLE BOND
|
English | 181.3 KB | ||
| 2013-07-01 08:10 |
Pharming and Shanghai Institute of Pharmaceutical Industry (SIPI) establish str…
|
English | 443.9 KB | ||
| 2013-06-25 11:02 |
Pharming And Santarus Announce Poster Presentation Of Pivotal Clinical Data For…
|
English | 223.2 KB | ||
| 2013-06-24 16:37 |
Pharming Elects To Redeem Fifth Tranche Of Convertible Bond For Cash
|
English | 194.8 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
